SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Sharps Compliance Corp. (SMED) trades at a trailing P/E of 11.5. Trailing earnings yield is 8.69%. PEG 0.03 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (11.5); PEG ≤ 1.0 — Peter Lynch undervalued (0.03); earnings yield beats bond yields (8.69%).
- PEG Ratio 0.03 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 8.69% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 78/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SMED
Valuation Multiples
P/E (TTM)11.5
Forward P/EN/A
PEG Ratio0.03
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.95
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.76
Book Value / Share$0.00
Revenue / Share$4.49
FCF / Share$0.00
Yields & Fair Value
Earnings Yield8.69%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2012 |
$-0.24 |
$21.79M |
$-3.62M |
-16.6% |
| 2013 |
$-0.18 |
$21.53M |
$-2.71M |
-12.6% |
| 2014 |
$0.06 |
$26.57M |
$956K |
3.6% |
| 2015 |
$0.07 |
$30.9M |
$1.16M |
3.8% |
| 2016 |
$0.00 |
$33.38M |
$13K |
0% |
| 2017 |
$-0.08 |
$38.19M |
$-1.29M |
-3.4% |
| 2018 |
$-0.04 |
$40.14M |
$-672K |
-1.7% |
| 2019 |
$0.01 |
$44.31M |
$214K |
0.5% |
| 2020 |
$0.14 |
$51.15M |
$2.27M |
4.4% |
| 2021 |
$0.76 |
$76.42M |
$12.87M |
16.8% |
